- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Rare Tumors
Total 151646 results
-
Advanced Accelerator ApplicationsCompletedCarcinoid Tumor of the Small Bowel | Neuroendocrine TumourUnited States, United Kingdom, Italy, Belgium, France, Germany, Portugal, Spain
-
Vanquish Oncology, Inc.University of Illinois at ChicagoCompletedSolid Tumor | Neuroendocrine Tumors | Pancreatic Neuroendocrine TumorUnited States
-
Australasian Gastro-Intestinal Trials GroupCompletedMidgut Neuroendocrine Tumours | Pancreatic Neuroendocrine TumoursAustralia
-
Dana-Farber Cancer InstituteBayer; NovartisCompletedNeuroendocrine Tumor | Carcinoid Tumor | Pancreatic Neuroendocrine TumorUnited States
-
IpsenCompletedNeuroEndocrine TumoursUnited Kingdom
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Novartis; Beth Israel Deaconess Medical Center; Brigham and Women's HospitalCompletedNeuroendocrine Tumor | Carcinoid Tumor | Pancreatic Neuroendocrine TumorUnited States
-
National Cancer Institute (NCI)RecruitingSolid Tumor | Refractory Solid Tumors | Malignant Solid Tumors | Other Neoplasms Solid Tumors | Pediatric Solid TumorUnited States
-
Roswell Park Cancer InstituteNeuroEndocrine Tumor Research Foundation (NETRF)RecruitingLung Atypical Carcinoid Tumor | Metastatic Pancreatic Neuroendocrine Tumor | Lung Typical Carcinoid TumorUnited States
-
IpsenCompletedMidgut Neuroendocrine Tumours | Pancreatic TumoursSpain, United Kingdom, Denmark, Belgium, Germany, France, Netherlands, Ireland, Italy, Poland
-
National Cancer Institute (NCI)Active, not recruitingNeuroendocrine Tumor | Neuroendocrine Neoplasm | Colorectal Neuroendocrine Tumor G1 | Gastric Neuroendocrine Tumor G1 | Neuroendocrine Tumor G2United States
-
University of California, San FranciscoPeterson Family FoundationTerminatedNeuroendocrine Tumor | Neuroblastoma | Paraganglioma | Carcinoid TumorsUnited States
-
Gustave Roussy, Cancer Campus, Grand ParisCompletedMetastatic, Cerebral Primitive Neuroectodermal TumorsFrance
-
AC Camargo Cancer CenterH. Lee Moffitt Cancer Center and Research InstituteCompletedNeuroendocrine Tumors | Estrogen Receptor Positive Tumor | Progesterone Receptor Positive TumorUnited States, Brazil
-
David BushnellNational Cancer Institute (NCI); National Institutes of Health (NIH); Holden...Active, not recruitingNeuroendocrine Tumor Gastrointestinal, Hormone-Secreting | Neuroendocrine Tumor, MalignantUnited States
-
Dana-Farber Cancer InstituteCompletedCarcinoid Tumor | Pancreatic Neuroendocrine TumorUnited States
-
Children's Cancer and Leukaemia GroupUnknownBrain and Central Nervous System TumorsUnited Kingdom, Ireland
-
Yusuf MendaNational Cancer Institute (NCI); Holden Comprehensive Cancer Center; Perspective...Enrolling by invitationNeuroendocrine Tumor Grade 2 | Neuroendocrine Tumor Grade 1United States
-
NantCell, Inc.CompletedSarcoma | Ewing's Sarcoma | Primitive Neuroectodermal Tumors (PNETs) | Askin's Tumors | Desmoplastic Small Round Cell Tumors | Estraosseous Ewing's Tumor | Ewing's Family Tumor
-
University Medical Center GoettingenRecruitingPelvic Tumor | Thoracic TumorGermany
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedBrain Tumor | Central Nervous System TumorUnited States, Canada, Australia, Puerto Rico
-
St. Jude Children's Research HospitalCompletedBrain and Central Nervous System TumorsUnited States, Australia, Canada
-
National Cancer Institute (NCI)RecruitingMetastatic Midgut Neuroendocrine Tumor | Unresectable Midgut Neuroendocrine Tumor | Metastatic Midgut Neuroendocrine Tumor G1 | Metastatic Midgut Neuroendocrine Tumor G2United States, Canada
-
University of IowaNovartisNot yet recruitingNeuroendocrine Tumors | Neuroendocrine Tumor Grade 2 | Neuroendocrine Tumor Grade 1United States
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingAdvanced Gastroenteropancreatic Neuroendocrine TumorChina
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedBrain Tumor | Central Nervous System TumorUnited States, Canada, Puerto Rico, Australia, Netherlands, New Zealand, Switzerland
-
Pediatric Brain Tumor ConsortiumNational Cancer Institute (NCI)CompletedBrain and Central Nervous System TumorsUnited States
-
IpsenTerminatedNeuroendocrine TumoursUnited Kingdom, France, Germany, Australia, Italy
-
St. Jude Children's Research HospitalNational Cancer Institute (NCI)CompletedBrain and Central Nervous System TumorsUnited States, Australia
-
Peter AndersonCompletedMetastatic Neuroendocrine Tumor | Recurrent Neuroendocrine TumorUnited States
-
Jiangsu HengRui Medicine Co., Ltd.Not yet recruitingAdvanced Gastroenteropancreatic Neuroendocrine Tumor
-
Francesco De CobelliCompleted
-
Molecular Insight Pharmaceuticals, Inc.Withdrawn
-
University Medical Center GroningenCompletedNeuroendocrine TumorNetherlands
-
Thomas HopeCompletedNeuroendocrine TumorUnited States
-
Samsung Medical CenterCompletedNeuroendocrine TumorKorea, Republic of
-
Nuclear Medicine Consultants, Inc.Unknown
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham...CompletedNeuroendocrine TumorUnited States
-
Burzynski Research InstituteTerminatedPrimitive Neuroectodermal TumorUnited States
-
Arcispedale Santa Maria Nuova-IRCCSCompletedNeuroendocrine TumoursAustria, Italy
-
Grupo Espanol de Tumores NeuroendocrinosActive, not recruitingNeuroendocrine Tumors | Neuroendocrine Neoplasm | Gastroenteropancreatic Neuroendocrine TumorSpain
-
IpsenCompleted
-
IpsenCompleted
-
IpsenCompletedGastro-Enteropancreatic Neuroendocrine TumorUnited States, Austria, Denmark
-
Universitätsklinikum Hamburg-EppendorfCompletedBrain and Central Nervous System TumorsGermany
-
Children's Hospital Los AngelesNational Cancer Institute (NCI)CompletedBrain and Central Nervous System TumorsUnited States, Canada
-
AstraZenecaCompletedRefractory Solid Tumors | Cancer TumorUnited States
-
University Medical Center GroningenCompletedNeuroendocrine TumorNetherlands
-
University Medical Center GroningenCompletedNeuroendocrine TumorNetherlands
-
Novartis PharmaceuticalsCompletedNeuroendocrine TumorUnited States
-
Fox Chase Cancer CenterNational Cancer Institute (NCI)UnknownMolecular Analysis in Tissue Samples From Patients With Advanced or Metastatic Neuroendocrine TumorsNeuroendocrine TumorUnited States